Country-specific prevalence and clinical relevance of elevated Lp(a) as a risk enhancer in 2 Greek cohorts
Elevated Lp(a) levels were observed in 8.3% of the general population cohort and up to 23.9% in participants with ASCVD from the lipid clinic cohort, highlighting a risk gradient across ASCVD categories. Incorporating Lp(a) as a risk enhancer improves ASCVD risk reclassification beyond the validated HellenicSCOREII+.
Authors
- Georgios Georgiopoulos (ORCID: https://orcid.org/0000-0001-7661-5253)
- Yannis Skoumas
- Lasthenis Angelidakis
- Elisabeth C. Samouilidou (ORCID: https://orcid.org/0000-0001-8992-0564)
- Peggy Kostakou (ORCID: https://orcid.org/0000-0002-3821-224X)
- Angeliki-Maria Dimopoulou (ORCID: https://orcid.org/0000-0002-7339-4886)
- Nikolaos Rachiotis
- Konstantinos Stellos
- Achilleas Zacharoulis
- Polyxeni Manifava
- Panagiotis Nastatos
- Christina Chrysochoou
- Demosthenes Panagiotakos
- Stavros Athanasopoulos
- Evangellos Liberopoulos
- Christina Konstantaki
- Lydia Kokkininou
- Kimon Stamatelopoulos
- Georgios Zervas
- Dimitrios Papoutsis
- Dimitrios Delialis
- Georgios Mavraganis
- Kateryna Sopova
- Sofia-Panagiota Giannakopoulou
- Christos Pitsavos
Institutions
- National and Kapodistrian University of Athens (GR)
- Heidelberg University (DE)
- University Hospital Heidelberg (DE)
- Harokopio University of Athens (GR)
- Alexandra Hospital (GR)
- Eginition Hospital (GR)
- University Medical Centre Mannheim (DE)
- Hippocration General Hospital (GR)
- Evangelismos Hospital (GR)
Publication Details
- Journal
- Journal of clinical lipidology
- Published
- 2025-12-23
- DOI
- https://doi.org/10.1016/j.jacl.2025.12.016
- Citations
- 1
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 2.01